BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 6714411)

  • 1. [Compounds with potential gastric antisecretory and anti-ulcer activity. IV. Synthesis of 3- and 4-phenyl-2-oxo-5-[2-(methylpiperazine-1-yl)-acetyl]- 1H-2,3,4,5-tetrahydropyrido[2,3-b] [1,4]diazepine].
    Bianchi M; Butti A
    Farmaco Sci; 1984 Feb; 39(2):162-70. PubMed ID: 6714411
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Indolin-2,3-dione-3,N-alkylamino- and 3,N-piperazinoacetylhydrazones, new substances with anti-ulcer and antisecretory activity].
    Catto A; Cappelletti R; Leonardi A; Maggi F; Tajana A; Nardi D
    Farmaco Sci; 1983 Aug; 38(8):559-70. PubMed ID: 6617851
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New derivatives of pyrrolo and pyrido[2,1-b] quinazoline as antiulcer agents.
    Doria G; Passarotti C; Magrini R; Sala R; Sberze P; Tibolla M; Arcari G; Ceserani R; Castello R
    Farmaco Sci; 1984 Nov; 39(11):968-78. PubMed ID: 6519266
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-ulcer and antisecretory activity of selected imidazopiperidines.
    Arcari G; Bernardi L; Cimaschi R; Falconi G; Luini F; Scarponi U
    Arzneimittelforschung; 1984; 34(11):1467-71. PubMed ID: 6543121
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spirocyclopropane compounds. IV. Synthesis of 5-acetylspiro-[benzofuran-2(3H),1'-cyclopropan]-3-one related compounds for evaluation as gastric antisecretory and antiulcer agents.
    Watanabe M; Kawada M; Hirata T; Maki Y; Imada I
    Chem Pharm Bull (Tokyo); 1984 Sep; 32(9):3551-60. PubMed ID: 6525650
    [No Abstract]   [Full Text] [Related]  

  • 6. Synthesis of novel pyridotriazepinones as antisecretory agents.
    Kodato S; Wada H; Saito S; Takeda M; Nishibata Y; Aoe K; Date T; Onoda Y; Tamaki H
    Chem Pharm Bull (Tokyo); 1987 Jan; 35(1):80-9. PubMed ID: 3594670
    [No Abstract]   [Full Text] [Related]  

  • 7. Spirocyclopropane compounds. III. Synthesis of spiro[benzofuran-2(3H),1'-cyclopropan]-3-ones for evaluation as gastric antisecretory and antiulcer agents.
    Kawada M; Watanabe M; Okamoto K; Sugihara H; Hirata T; Maki Y; Imada I; Sanno Y
    Chem Pharm Bull (Tokyo); 1984 Sep; 32(9):3532-50. PubMed ID: 6525649
    [No Abstract]   [Full Text] [Related]  

  • 8. Synthesis and antiulcer activity of (E)-5-[2-(3-pyridyl)ethenyl]-1H,7H-pyrazolo [1,5-a]pyrimidine-7-ones.
    Doria G; Passarotti C; Sala R; Magrini R; Sberze P; Tibolla M; Ceserani R; Castello R
    Farmaco Sci; 1986 Jun; 41(6):417-29. PubMed ID: 3743739
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bicyclic compounds with potential antiulcer and/or antisecretory activity. II. 1(or 3),4,6,7-Tetrahydro-1(3)H-pyrano[3,4-d]imidazoles and 1(or 3),4,6,7-tetrahydro-1(3)H-thiopyrano[3,4-d]imidazoles.
    Scarponi U; Cimaschi R; Arcari G; Toti D; Ballabio M; Gandini E; de Castiglione R
    Farmaco Sci; 1986 Jan; 41(1):23-40. PubMed ID: 3956716
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies on new antiulcer agents. I. Synthesis and antisecretory activity of pyridazine derivatives.
    Yamada T; Nobuhara Y; Shimamura H; Yoshihara K; Yamaguchi A; Ohki M
    Chem Pharm Bull (Tokyo); 1981 Dec; 29(12):3433-9. PubMed ID: 7340942
    [No Abstract]   [Full Text] [Related]  

  • 11. [Compounds with anti-gastric secretion and antiulcer activity. V. Derivatives of 3,3,4a,6,7,11b-hexahydro-2H,5H-benzo [1,4]cyclohep[1,2-b][1,4]-oxazine and related products].
    Bianchi M; Butti A; Pfeiffer U; Rossi S; Barzaghi F; Marcaria V; Nencioni A
    Farmaco Sci; 1986 Mar; 41(3):229-56. PubMed ID: 3709787
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of alpha2 agonists clonidine, guanfacine and B-HT 920 on gastric acid secretion and ulcers in rats.
    Kunchandy J; Khanna S; Kulkarni SK
    Arch Int Pharmacodyn Ther; 1985 May; 275(1):123-38. PubMed ID: 2862848
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analgesic and antiinflammatory properties of the pirolo-[3,4-e] [1,4]-diazepine derivatives.
    Stochla K; Dorociak A; Makulska HE
    Pol J Pharmacol Pharm; 1984; 36(6):665-74. PubMed ID: 6336000
    [TBL] [Abstract][Full Text] [Related]  

  • 14. YM022 [(R)-1-[2,3-dihydro-1-(2'-methylphenacyl)-2-oxo-5-phenyl- 1H-1,4-benzodiazepin-3-yl]-3-(3-methylphenyl)urea], a potent and selective gastrin/cholecystokinin-B receptor antagonist, prevents gastric and duodenal lesions in rats.
    Nishida A; Takinami Y; Yuki H; Kobayashi A; Akuzawa S; Kamato T; Ito H; Yamano M; Nagakura Y; Miyata K
    J Pharmacol Exp Ther; 1994 Sep; 270(3):1256-61. PubMed ID: 7932178
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gastric cytoprotective, antisecretory and antiulcer activities of (E)-4-oxo-4-(3,4,5-trimethoxyphenyl)-2-butenoic acid (RU 38086).
    Barzaghi F; Cesana R; Delevallée F; Fournex R; Nencioni A; Vincent JC; Deraedt R
    Arzneimittelforschung; 1985; 35(9):1412-6. PubMed ID: 4084342
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Synthesis of pyrazolo[3,4-e][1,4]diazepine-4,7-diones with central nervous system activity].
    Sprio V; Caronna S; Migliara O; Petruso S; Matera M
    Farmaco; 1989 Sep; 44(9):809-18. PubMed ID: 2604835
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and antiulcer activity of (isochroman-1-yl)alkylamines. II.
    Yamato M; Hashigaki K; Hitomi S; Ishikawa S
    Chem Pharm Bull (Tokyo); 1988 Sep; 36(9):3453-61. PubMed ID: 3240539
    [No Abstract]   [Full Text] [Related]  

  • 18. Synthesis and biological action of some derivatives of pyrido-[1,4]-diazepine and pyrido-[2,3-d]-pyrimidine.
    Sołoducho J; Mrozikiewicz A; Bobkiewicz-Kozłowska T; Olejnik A; Pieczyńska A
    Pol J Pharmacol Pharm; 1985; 37(4):541-50. PubMed ID: 4080648
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The influence of 2-(4-methylaminobutoxy)diphenylmethane hydrochloride (MCI-2016) on gastric ulcer and gastric acid secretion.
    Tobe A; Yoshida Y; Egawa M
    Arzneimittelforschung; 1983; 33(3):397-400. PubMed ID: 6683513
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Synthesis, antisecretory, and anti-ulcer activity of new 5-arylidene-2-ureidoalkyl-3-pyridazinones].
    Rubat C; Coudert P; Couquelet J; Bastide P; Bastide J
    Farmaco Sci; 1988 Dec; 43(12):1035-44. PubMed ID: 3248593
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.